This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Feb 10;352(6):536-8.

doi: 10.1056/NEJMp048266.

Myelodysplastic syndromes--coping with ineffective hematopoiesis

Mario Cazzola¹, Luca Malcovati

Affiliations

PMID: 15703418
DOI: 10.1056/NEJMp048266

Comment

Myelodysplastic syndromes--coping with ineffective hematopoiesis

Mario Cazzola et al. N Engl J Med. 2005.

. 2005 Feb 10;352(6):536-8.

doi: 10.1056/NEJMp048266.

Authors

Mario Cazzola¹, Luca Malcovati

Affiliation

¹ University of Pavia Medical School, Pavia, Italy.

PMID: 15703418
DOI: 10.1056/NEJMp048266

No abstract available

PubMed Disclaimer

Comment in

Treatment of myelodysplastic syndromes.
Stadler M, Ganser A. Stadler M, et al. N Engl J Med. 2005 May 19;352(20):2134-5; author reply 2134-5. N Engl J Med. 2005. PMID: 15906434 No abstract available.

Comment on

Efficacy of lenalidomide in myelodysplastic syndromes.
List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D, Rimsza L, Heaton R, Knight R, Zeldis JB. List A, et al. N Engl J Med. 2005 Feb 10;352(6):549-57. doi: 10.1056/NEJMoa041668. N Engl J Med. 2005. PMID: 15703420 Clinical Trial.

Similar articles

Treatment of myelodysplastic syndromes.
Stadler M, Ganser A. Stadler M, et al. N Engl J Med. 2005 May 19;352(20):2134-5; author reply 2134-5. N Engl J Med. 2005. PMID: 15906434 No abstract available.
Efficacy of lenalidomide in myelodysplastic syndromes.
List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D, Rimsza L, Heaton R, Knight R, Zeldis JB. List A, et al. N Engl J Med. 2005 Feb 10;352(6):549-57. doi: 10.1056/NEJMoa041668. N Engl J Med. 2005. PMID: 15703420 Clinical Trial.
New agents in the treatment of MDS.
List AF. List AF. Clin Adv Hematol Oncol. 2005 Nov;3(11):832-4. Clin Adv Hematol Oncol. 2005. PMID: 16491623 No abstract available.
New therapeutic approaches in myelodysplastic syndromes: Hypomethylating agents and lenalidomide.
Loiseau C, Ali A, Itzykson R. Loiseau C, et al. Exp Hematol. 2015 Aug;43(8):661-72. doi: 10.1016/j.exphem.2015.05.014. Epub 2015 Jun 27. Exp Hematol. 2015. PMID: 26123365 Review.
Thalidomide therapy for myelodysplastic syndromes: current status and future perspectives.
Musto P. Musto P. Leuk Res. 2004 Apr;28(4):325-32. doi: 10.1016/j.leukres.2003.08.007. Leuk Res. 2004. PMID: 15109529 Review.

See all similar articles

Cited by

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP, Abedi M, Bejar R, Cogle CR, Foucar K, Garcia-Manero G, George TI, Grinblatt D, Komrokji R, Ma X, Maciejewski J, Pollyea DA, Savona MR, Scott B, Sekeres MA, Thompson MA, Swern AS, Nifenecker M, Sugrue MM, Erba H. Steensma DP, et al. BMC Cancer. 2016 Aug 19;16:652. doi: 10.1186/s12885-016-2710-6. BMC Cancer. 2016. PMID: 27538433 Free PMC article.
Incidence and Burden of the Myelodysplastic Syndromes.
Cogle CR. Cogle CR. Curr Hematol Malig Rep. 2015 Sep;10(3):272-81. doi: 10.1007/s11899-015-0269-y. Curr Hematol Malig Rep. 2015. PMID: 26134527 Free PMC article. Review.
Influence of Prognostic Factors on OverallSurvival in Myelodysplastic Syndromes.
Sotirova T, Stojanovic A, Genadieva-Stavric S, Krstevska S, Spasovski D, Balkanov T. Sotirova T, et al. Mater Sociomed. 2014 Oct;26(5):292-6. doi: 10.5455/msm.2014.26.292-296. Epub 2014 Oct 29. Mater Sociomed. 2014. PMID: 25568624 Free PMC article.
Guidelines on haemovigilance of post-transfusional iron overload.
Remacha A, Sanz C, Contreras E, De Heredia CD, Grifols JR, Lozano M, Nuñez GM, Salinas R, Corral M, Villegas A; Spanish Society of Blood Transfusion; Spanish Society of Haematology and Haemotherapy. Remacha A, et al. Blood Transfus. 2013 Jan;11(1):128-39. doi: 10.2450/2012.0114-11. Epub 2012 Jul 4. Blood Transfus. 2013. PMID: 22790272 Free PMC article. Review. No abstract available.
Iron chelation therapy in myelodysplastic syndromes.
Messa E, Cilloni D, Saglio G. Messa E, et al. Adv Hematol. 2010;2010:756289. doi: 10.1155/2010/756289. Epub 2010 Jun 20. Adv Hematol. 2010. PMID: 20672005 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information